Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Biochemical Pharmacology|May 15, 2002
Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug releaseSteven A Everett, Elizabeth Swann, Matthew A Naylor, et al.
BMJ Military Health|July 24, 2021
Physical sleeping environment is related to insomnia risk and measures of readiness in US army special operations soldiersJanna Mantua, B M Ritland, J A Naylor, et al.
Journal of Medicinal Chemistry|September 1, 1990
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxinsT C Jenkins, M A Naylor, P O'Neill, et al.
The Review of Scientific Instruments|January 1, 2008
A hyperspectral fluorescence lifetime probe for skin cancer diagnosisP A A De Beule, C Dunsby, N P Galletly, et al.
International Journal of Pharmaceutics|May 11, 2011
Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technologyAj Baxendale, P van Hooff, L G Durrant, et al.
Applied Optics|October 22, 2010
Design and performance of cryogenic, scanning Fabry-Perot interferometers for the Long-Wavelength Spectrometer on the Infrared Space ObservatoryG R Davis, I Furniss, W A Towlson, et al.
Current Topics in Medicinal Chemistry|June 8, 2002
Evaluation and development of spinosyns to control ectoparasites on cattle and sheepHerbert A Kirst, Lawrence C Creemer, Sharon A Naylor, et al.
Arthritis Research & Therapy|August 18, 2019
11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapyC G Fenton, C L Doig, S Fareed, et al.
The Journal of Antibiotics|December 1, 1996
Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistryG Burton, G J Clarke, J D Douglas, et al.
Cancer Research|December 25, 2002
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculaturePeter D Davis, Graeme J Dougherty, David C Blakey, et al.
Pageof 28